Production and characterization of exopolysaccharides from Pseudomonas aeruginosa AG01 with some medical potential applications

铜绿假单胞菌AG01胞外多糖的生产和表征及其在医学上的潜在应用

阅读:1

Abstract

There is growing interest in the production and characterization of bacterial exopolysaccharides (EPS) because of their diverse range of applications. This study aimed to examine the production of EPS by Pseudomonas aeruginosa AG01, to characterize the produced EPS and its application as antioxidant, antimicrobial, antibiofilm, antitumor, and antiviral activity. The results indicated that the ideal conditions for achieving the highest production of EPS included an incubation period of 96 h, a pH level of 6, and a temperature of 32 °C in a nutrient broth medium. The most efficient sources of carbon and nitrogen for the formation of EPS were found to be galactose, glucose, yeast extract, and peptone. Several functional groups were confirmed to be present by Fourier transform infrared spectroscopy including amino groups, amides, carboxylic acids, hydroxyl groups, and phosphates. In the same respect, EPS has antioxidant activity. Moreover, EPS produced by Pseudomonas aeruginosa AG01 demonstrated antibacterial activity against various Gram-positive, Gram-negative bacteria, and yeast, besides antibiofilm activity about 98.93%, 98.86%, 98.63%, and 97.19% for Bacillus subtilis, Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli, respectively as well as anticancer activity against prostate cancer (PC3) and breast cancer (MCF7) cells with IC50 values of 156.41 and 156.41 µg/ml, respectively. Flow cytometry analysis revealed that MCF7 cells treated with EPS at a concentration of 500 µg/ml for 48 h showed a reduction in the percentage of cells in both the G0/G1 and S phases compared to the untreated control MCF7 cells. EPS resulted in apoptosis induction in MCF7 cells using the Annexin V-FITC PI staining method. The findings indicate that EPS demonstrates significant antiviral activity against both the herpes simplex virus (HSV-1) and the hepatitis A virus (HAV). In conclusion, EPS has great potential to be developed as a natural antioxidant or used in medicine and pharmaceuticals.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。